MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Marketable securities,current$351,028K Cash and cashequivalents$161,154K Prepaid expenses andother current assets$16,919K Restricted cash$400K Property and equipment,gross$186,161K Total current assets$529,501K Property and equipment,net$138,067K Operating leaseright-of-use assets$91,066K Marketable securities,non-current$83,828K Restricted cash,non-current$7,808K Other non-currentassets$556K Less accumulateddepreciation$48,094K Total assets$850,826K Total liabilities,redeemable convertible...$850,826K Total stockholders'equity (deficit)$550,671K Total liabilities$300,155K Accumulated deficit-$1,003,467K Additional paid-in capital$1,554,133K Operating leaseliability, non-current$245,091K Total currentliabilities$45,064K Other non-currentliabilities$10,000K Common stock, 0.0001par value...$5K Accrued expenses andother current...$29,319K Operating leaseliability, current$9,740K Accounts payable$6,005K
Balance Sheet

Eikon Therapeutics, Inc. (EIKN)

Eikon Therapeutics, Inc. (EIKN)

source: myfinsight.com